☰

cached image

Jung-Mo Ahn, Ph.D. - Publications

Affiliations: 
2000 University of Arizona, Tucson, AZ 
 2004- University of Texas at Dallas, Richardson, TX, United States 
Area:
Organic Chemistry, Biochemistry, Chemical Biology and Medicinal Chemistry
Website:
https://www.utdallas.edu/chemistry/faculty/ahn.html
Tree Info Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Viswanadhapalli S, Ma S, Lee TK, Liu X, Kassees K, Pratap UP, Liu J, Tang W, Tekmal RR, Ahn J, Raj GV, Vadlamudi RK. Abstract 5676: Preclinical evaluation of estrogen receptor coregulator binding inhibitor ERX-245 in breast cancer Cancer Research. 80: 5676-5676. DOI: 10.1158/1538-7445.Am2020-5676  0.338
2019 Raj GV, Liu X, Ekoue D, Ahn J, Vadlamudi R. Abstract 26: Development of potent lead compounds in multiple tumor types Cancer Research. 79: 26-26. DOI: 10.1158/1538-7445.Sabcs18-26  0.321
2017 Raj GV, Sareddy GR, Ma S, Lee T, Viswanadhapalli S, Li R, Liu X, Murakami S, Chen C, Lee W, Mann M, Krishnan SR, Manandhar B, Gonugunta VK, Strand D, ... ... Ahn J, et al. Author response: Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers Elife. DOI: 10.7554/Elife.26857.081  0.352
2016 Graaf C, Donnelly D, Wootten D, Lau J, Sexton PM, Miller LJ, Ahn JM, Liao J, Fletcher MM, Yang D, Brown AJ, Zhou C, Deng J, Wang MW. Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes. Pharmacological Reviews. 68: 954-1013. PMID 27630114 DOI: 10.1124/pr.115.011395  0.368
2016 Vadlamudi RK, Sareddy GR, Viswanadhapalli S, Lee T, Ma S, Lee WR, Mann M, Krishnan SR, Gonugunta V, Strand DW, Tekmal RR, Ahn J, Raj GV. Abstract B08: ESR1 coregulator binding site inhibitors (ECBIs) as novel therapeutics to target hormone therapy-resistant breast cancer Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-B08  0.305
2016 Vadlamudi RK, Sareddy GR, Viswanadhapalli S, Lee T, Ma S, Lee WR, Mann M, Krishnan SR, Gonugunta V, Liu Y, Strand DW, Tekmal RR, Ahn J, Raj GV. Abstract 860: ESR1 coregulator binding inhibitor (ECBI): a novel agent for treating hormone therapy-resistant breast cancer Cancer Research. 76: 860-860. DOI: 10.1158/1538-7445.Am2016-860  0.319
2011 Gao H, Niu G, Yang M, Quan Q, Ma Y, Murage EN, Ahn JM, Kiesewetter DO, Chen X. PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue. Molecular Pharmaceutics. 8: 1775-82. PMID 21800885 DOI: 10.1021/mp200141x  0.667
2010 Murage EN, Gao G, Bisello A, Ahn JM. Development of potent glucagon-like peptide-1 agonists with high enzyme stability via introduction of multiple lactam bridges. Journal of Medicinal Chemistry. 53: 6412-20. PMID 20687610 DOI: 10.1021/jm100602m  0.729
2009 Murage E, Beinborn M, Ahn JM. Seeking for alpha-helical propensity in a receptor-bound conformation of glucagon-like peptide-1. Advances in Experimental Medicine and Biology. 611: 289-90. PMID 19400196  0.729
2009 Ahn JM, Han SY, Murage E, Beinborn M. Rational design of peptidomimetics for class B GPCRs: potent non-peptide GLP-1 receptor agonists. Advances in Experimental Medicine and Biology. 611: 125-6. PMID 19400122  0.709
2008 Murage EN, Schroeder JC, Beinborn M, Ahn JM. Search for alpha-helical propensity in the receptor-bound conformation of glucagon-like peptide-1. Bioorganic & Medicinal Chemistry. 16: 10106-12. PMID 18952440 DOI: 10.1016/j.bmc.2008.10.006  0.729
2004 Ahn JM, Wentworth P, Janda KD. Probing lipase/esterase libraries for lipid A hydrolases--discovery of biocatalysts for the detoxification of bacterially-expressed recombinant protein. Chemical Communications (Cambridge, England). 364-5. PMID 14765210 DOI: 10.1039/B312662E  0.34
2003 Moss JA, Coyle AR, Ahn JM, Meijler MM, Offer J, Janda KD. Tandem IMAC-HPLC purification of a cocaine-binding scFv antibody. Journal of Immunological Methods. 281: 143-8. PMID 14580888 DOI: 10.1016/J.Jim.2003.07.010  0.579
2003 Ahn JM, Wentworth P, Janda KD. Soluble polymer-supported convergent parallel library synthesis. Chemical Communications (Cambridge, England). 480-1. PMID 12638959 DOI: 10.1039/B210696E  0.318
2003 Ying J, Ahn JM, Jacobsen NE, Brown MF, Hruby VJ. NMR solution structure of the glucagon antagonist [desHis1, desPhe6, Glu9]glucagon amide in the presence of perdeuterated dodecylphosphocholine micelles. Biochemistry. 42: 2825-35. PMID 12627948 DOI: 10.1021/Bi026629R  0.613
2002 Ahn JM, Boyle NA, MacDonald MT, Janda KD. Peptidomimetics and peptide backbone modifications. Mini Reviews in Medicinal Chemistry. 2: 463-73. PMID 12370047 DOI: 10.2174/1389557023405828  0.456
2002 Moens K, Berger V, Ahn JM, Van Schravendijk C, Hruby VJ, Pipeleers D, Schuit F. Assessment of the role of interstitial glucagon in the acute glucose secretory responsiveness of in situ pancreatic beta-cells. Diabetes. 51: 669-75. PMID 11872665 DOI: 10.2337/Diabetes.51.3.669  0.382
2002 Cowell SM, Balse-Srinivasan PM, Ahn JM, Hruby VJ. Design and synthesis of peptide antagonists and inverse agonists for G protein-coupled receptors. Methods in Enzymology. 343: 49-72. PMID 11665587 DOI: 10.1016/S0076-6879(02)43127-8  0.523
2001 Ahn JM, Gitu PM, Medeiros M, Swift JR, Trivedi D, Hruby VJ. A new approach to search for the bioactive conformation of glucagon: positional cyclization scanning. Journal of Medicinal Chemistry. 44: 3109-16. PMID 11543679 DOI: 10.1021/Jm010091Q  0.55
2001 Ahn JM, Medeiros M, Trivedi D, Hruby VJ. Development of potent glucagon antagonists: structure-activity relationship study of glycine at position 4. The Journal of Peptide Research : Official Journal of the American Peptide Society. 58: 151-8. PMID 11532074 DOI: 10.1034/J.1399-3011.2001.00880.X  0.496
2001 Ahn JM, Medeiros M, Trivedi D, Hruby VJ. Development of potent truncated glucagon antagonists. Journal of Medicinal Chemistry. 44: 1372-9. PMID 11311060 DOI: 10.1021/Jm000453E  0.544
2000 Trivedi D, Lin Y, Ahn JM, Siegel M, Mollova NN, Schram KH, Hruby VJ. Design and synthesis of conformationally constrained glucagon analogues. Journal of Medicinal Chemistry. 43: 1714-22. PMID 10794689 DOI: 10.1021/Jm990559D  0.491
1998 Sturm NS, Lin Y, Burley SK, Krstenansky JL, Ahn JM, Azizeh BY, Trivedi D, Hruby VJ. Structure-function studies on positions 17, 18, and 21 replacement analogues of glucagon: the importance of charged residues and salt bridges in glucagon biological activity. Journal of Medicinal Chemistry. 41: 2693-700. PMID 9667960 DOI: 10.1021/Jm980084A  0.439
1997 Hruby VJ, Ahn JM, Liao S. Synthesis of oligopeptide and peptidomimetic libraries. Current Opinion in Chemical Biology. 1: 114-9. PMID 9667835 DOI: 10.1016/S1367-5931(97)80117-2  0.405
1997 Azizeh BY, Ahn JM, Caspari R, Shenderovich MD, Trivedi D, Hruby VJ. The role of phenylalanine at position 6 in glucagon's mechanism of biological action: multiple replacement analogues of glucagon. Journal of Medicinal Chemistry. 40: 2555-62. PMID 9258362 DOI: 10.1021/Jm960800D  0.433
Show low-probability matches.